Role of gut microbiota in doxorubicin-induced cardiotoxicity: from pathogenesis to related interventions
Journal of Translational Medicine · 2024
DOI: 10.1186/s12967-024-05232-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Translational Medicine, 2024. Verfasst von Chao Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Affiliated Hospital of Qingdao University, No. 59 Haier Road, Qingdao, Shandong, 266100, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Doxorubicin, Cardiotoxicity. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Project of Shandong Province Higher Educational Science and Technology Program.
Abstract (Originalsprache)
Doxorubicin (DOX) is a broad-spectrum and highly efficient anticancer agent, but its clinical implication is limited by lethal cardiotoxicity. Growing evidences have shown that alterations in intestinal microbial composition and function, namely dysbiosis, are closely linked to the progression of DOX-induced cardiotoxicity (DIC) through regulating the gut-microbiota-heart (GMH) axis. The role of gut microbiota and its metabolites in DIC, however, is largely unelucidated. Our review will focus on the potential mechanism between gut microbiota dysbiosis and DIC, so as to provide novel insights into the pathophysiology of DIC. Furthermore, we summarize the underlying interventions of microbial-targeted therapeutics in DIC, encompassing dietary interventions, fecal microbiota transplantation (FMT), probiotics, antibiotics, and natural phytochemicals. Given the emergence of microbial investigation in DIC, finally we aim to point out a novel direction for future research and clinical intervention of DIC, which may be helpful for the DIC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Affiliated Hospital of Qingdao University, No. 59 Haier Road, Qingdao, Shandong, 266100, China.
- Department of Genetics and Cell Biology, Basic Medical College, Qingdao University, No. 308 Ningxia Road, Qingdao, Shandong, 266000, China.
- Department of Gastroenterology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, 266000, China.
- Department of Genetics and Cell Biology, Basic Medical College, Qingdao University, No. 308 Ningxia Road, Qingdao, Shandong, 266000, China. libing_516@qdu.edu.cn.
- Department of Dermatology, The Affiliated Haici Hospital of Qingdao University, Qingdao, 266033, China. libing_516@qdu.edu.cn.
- Department of Cardiology, The Affiliated Hospital of Qingdao University, No. 59 Haier Road, Qingdao, Shandong, 266100, China. chuxianming@qdu.edu.cn.
ORCID-Profile: Xian-Ming Chu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Project of Shandong Province Higher Educational Science and Technology Program
- Taishan Scholar Foundation of Shandong Province
Zitieren
APA
Huang, C., Li, X., Li, H., Chen, R., Li, Z., Li, D., Xu, X., Zhang, G., Qin, L., Li, B., & Chu, X. M. (2024). Role of gut microbiota in doxorubicin-induced cardiotoxicity: from pathogenesis to related interventions. Journal of Translational Medicine. https://doi.org/10.1186/s12967-024-05232-5
Vancouver
Huang C, Li X, Li H, Chen R, Li Z, Li D, et al. Role of gut microbiota in doxorubicin-induced cardiotoxicity: from pathogenesis to related interventions. Journal of Translational Medicine. 2024. doi:10.1186/s12967-024-05232-5
BibTeX
@article{Huang2024,
author = {Huang, Chao and Li, Xiaoxia and Li, Hanqing and Chen, Ruolan and Li, Zhaoqing and Li, Daisong and Xu, Xiaojian and Zhang, Guoliang and Qin, Luning and Li, Bing and Chu, Xian-Ming},
title = {Role of gut microbiota in doxorubicin-induced cardiotoxicity: from pathogenesis to related interventions},
journal = {Journal of Translational Medicine},
year = {2024},
doi = {10.1186/s12967-024-05232-5}
}
EUVIMED